New York S05013 mandates health insurers to cover opioid antagonists and devices.

New York S05013 amends the insurance law to require health insurers to provide coverage for at least one opioid antagonist and device. This coverage applies to policies that cover prescription drugs and may include naloxone and other medications approved by the Department of Health. Prior authorization may be required for non-generic forms of opioid antagonists and devices. The coverage can be subject to annual deductibles and co-insurance, consistent with other benefits within the policy.

New York S05013 mandates health insurers to cover opioid antagonists and devices.

New York S05013 amends the insurance law to require health insurers to provide coverage for at least one opioid antagonist and device. This coverage applies to policies that cover prescription drugs and may include naloxone and other medications approved by the Department of Health. Prior authorization may be required for non-generic forms of opioid antagonists and devices. The coverage can be subject to annual deductibles and co-insurance, consistent with other benefits within the policy.